Total Payments
$19,066
2024 Payments
$2,254
Companies
56
Transactions
406
Medicare Patients
1,388
Medicare Billing
$251,805
Payment Breakdown by Category
Food & Beverage$17,075 (89.6%)
Research$1,448 (7.6%)
Travel$499.40 (2.6%)
Education$43.93 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,075 | 393 | 89.6% |
| Unspecified | $1,448 | 5 | 7.6% |
| Travel and Lodging | $499.40 | 3 | 2.6% |
| Education | $43.93 | 5 | 0.2% |
Payments by Type
General
$17,618
401 transactions
Research
$1,448
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $2,064 | 53 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $2,003 | 38 | $0 (2024) |
| Abbott Laboratories | $1,524 | 19 | $0 (2024) |
| Novo Nordisk AS | $1,448 | 5 | $0 (2022) |
| Amgen Inc. | $1,060 | 40 | $0 (2024) |
| PFIZER INC. | $1,021 | 31 | $0 (2024) |
| ATRICURE, INC. | $798.62 | 8 | $0 (2024) |
| Novo Nordisk Inc | $782.81 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $728.44 | 13 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $674.57 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,254 | 35 | AstraZeneca Pharmaceuticals LP ($336.81) |
| 2023 | $2,812 | 57 | AstraZeneca Pharmaceuticals LP ($365.49) |
| 2022 | $3,867 | 60 | Novo Nordisk AS ($1,448) |
| 2021 | $2,802 | 74 | AstraZeneca Pharmaceuticals LP ($514.41) |
| 2020 | $1,244 | 53 | Abbott Laboratories ($215.72) |
| 2019 | $1,686 | 41 | Janssen Pharmaceuticals, Inc ($366.62) |
| 2018 | $2,076 | 46 | PFIZER INC. ($338.66) |
| 2017 | $2,324 | 40 | Janssen Pharmaceuticals, Inc ($658.96) |
All Payment Transactions
406 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $134.45 | General |
| Category: SURGERY | ||||||
| 12/20/2024 | Abbott Laboratories | EPIC (Device) | Food and Beverage | In-kind items and services | $159.81 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: GI | ||||||
| 12/04/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/13/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $111.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | Abbott Laboratories | ESPRIT (Device) | Food and Beverage | In-kind items and services | $145.92 | General |
| Category: Vascular | ||||||
| 09/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $94.60 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.93 | General |
| 08/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $107.63 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: Inflammation | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $66.78 | General |
| Category: SURGERY | ||||||
| 06/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Endocrinology | ||||||
| 06/03/2024 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $125.57 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/24/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $32.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $117.93 | General |
| Category: Cardio-renal | ||||||
| 05/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Inflammation | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $95.16 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NN9535-4321 | Novo Nordisk AS | $1,448 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 356 | 815 | $93,960 | $49,076 |
| 2022 | 6 | 270 | 949 | $117,105 | $63,064 |
| 2021 | 6 | 361 | 989 | $119,421 | $67,196 |
| 2020 | 11 | 401 | 1,188 | $139,959 | $72,470 |
Total Patients
1,388
Total Services
3,941
Medicare Billing
$251,805
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 298 | $35,760 | $19,016 | 53.2% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 36 | 282 | $33,840 | $15,178 | 44.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 58 | 58 | $12,760 | $7,581 | 59.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 32 | 32 | $3,195 | $2,427 | 76.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 12 | 18 | $2,700 | $1,954 | 72.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 67 | 67 | $2,010 | $1,241 | 61.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 38 | $2,980 | $1,107 | 37.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $385.00 | $347.16 | 90.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 11 | 11 | $330.00 | $225.06 | 68.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 68 | 468 | $56,160 | $25,738 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 357 | $42,840 | $25,664 | 59.9% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 55 | 77 | $11,550 | $7,980 | 69.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $3,480 | $2,279 | 65.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $2,325 | $1,223 | 52.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 15 | $750.00 | $179.01 | 23.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 116 | 401 | $46,983 | $28,996 | 61.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 98 | 429 | $51,480 | $24,320 | 47.2% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 99 | 109 | $16,350 | $11,716 | 71.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 15 | $2,430 | $1,198 | 49.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 17 | 17 | $1,344 | $750.89 | 55.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 16 | 18 | $834.00 | $213.52 | 25.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 138 | 508 | $57,570 | $28,046 | 48.7% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 78 | 383 | $45,960 | $22,067 | 48.0% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 67 | 85 | $12,734 | $9,191 | 72.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 87 | $9,370 | $5,307 | 56.6% |
About Dr. Cesar Figueroa, MD
Dr. Cesar Figueroa, MD is a Internal Medicine healthcare provider based in Delray Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063575231.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cesar Figueroa, MD has received a total of $19,066 in payments from pharmaceutical and medical device companies, with $2,254 received in 2024. These payments were reported across 406 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($17,075).
As a Medicare-enrolled provider, Figueroa has provided services to 1,388 Medicare beneficiaries, totaling 3,941 services with total Medicare billing of $251,805. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Delray Beach, FL
- Active Since 12/19/2006
- Last Updated 04/08/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063575231
Products in Payments
- Ozempic (Drug) $1,768
- XARELTO (Drug) $1,689
- FARXIGA (Drug) $1,023
- ELIQUIS (Drug) $770.66
- BREZTRI (Drug) $677.65
- Kerendia (Drug) $674.57
- Vascepa (Drug) $516.31
- NEXLIZET (Drug) $491.17
- Quadra Assura CRT Defibrillator (Device) $484.69
- JARDIANCE (Drug) $437.29
- ENTRESTO (Drug) $406.11
- INVOKANA (Drug) $375.29
- SYNERGY ABLATION SYSTEM (Device) $374.10
- Repatha (Biological) $363.08
- HETLIOZ (Drug) $338.64
- NURTEC ODT (Drug) $331.00
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $274.23
- PRADAXA (Drug) $268.95
- RYBELSUS (Drug) $263.27
- CHANTIX (Drug) $262.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Delray Beach
Dr. Luis Mora Vieira, Md, MD
Internal Medicine — Payments: $61,476
Internal Medicine $61,476
Dr. Barry Seidman, M.d, M.D
Internal Medicine — Payments: $31,321
Internal Medicine $31,321
Mohamed Erritouni, Md, MD
Internal Medicine — Payments: $29,886
Internal Medicine $29,886
Manuel Espinel, M.d, M.D
Internal Medicine — Payments: $25,408
Internal Medicine $25,408
Ivan Coronado, Md, MD
Internal Medicine — Payments: $17,621
Internal Medicine $17,621
James Chong, Md, MD
Internal Medicine — Payments: $15,830
Internal Medicine $15,830